CTSI

When reports of a highly infectious novel coronavirus emerged from China in January 2020, Sheila Murphy joined a team of fellow public-health experts at the Southern California Clinical and Translational Science Institute (SC CTSI). "From experience, we knew that for historical, socioeconomic and cultural reasons underserved populations would be less likely to get vaccinated. So, minority groups

In July 2021, the Southern California Healthcare Delivery Science (HDS) Center was established with the goal of advancing health system innovations through research awards, training, and collaborations with the Los Angeles County Department of Health Services and other partners. The Center is partially supported by the SC CTSI. The HDS Center strives to enhance healthcare access, quality of care

HERSHEY, Pa. — One of the greatest challenges faced by scientists and health care practitioners might be the translation of research findings from the lab to their implementation in real-world settings. In other words, the academic and research community is constantly innovating, finding new, evidence-based interventions to help improve people’s health and well-being. However, there is a gap

A new study published in the Journal of Infectious Diseases and led by Martin Zand, M.D., Ph.D., co-director of the University of Rochester Clinical and Translational Science Institute, shows that pre-existing immunity to the common cold may have put people at risk of more severe COVID illness and death. The study utilized the UR CTSI’s COVID Biobank to analyze antibodies in blood samples from

With proper business development tools and insights into entrepreneurship, biomedical researchers can improve the potential of their discoveries in the laboratory reaching patients. I-Corps@NCATS, a University of Miami (UM) Clinical and Translational Science Institute (CTSI) program, helps entrepreneurial-minded researchers move their new drugs, diagnostics, technologies, and devices forward to the next stage of development.

The SC Clinical and Translational Science Institute would like to welcome and congratulate our new cohort of Mentored Career Development in Clinical and Translational Science Program (KL2) Scholars! The KL2 program was created to support research career development for health professionals or individuals with research doctoral degrees who wish to pursue formal training and a career in clinical and

Many Chinese immigrant caregivers endure the fatigue and overwork known by caregivers everywhere. But they struggle with added burdens—language barriers, self-neglecting behavior, and social isolation—that heighten risks to their physical and mental health. That’s why USC researchers recruited Mandarin-speaking immigrant caregivers to co-design and pilot-test a mobile application as part of a self

No one wants to see a child in physical pain, but post-surgery treatment with opioids poses risks for addiction or other misuses. Surgeons have lacked effective guidance about prescribing opioids to manage a child’s pain after surgery. Now Lorraine Kelley-Quon, MD, MSHS, FACS, FAAP, (https://bit.ly/2StAqc6) a former SC CTSI KL2 Mentored Career Development Scholar, is helping to fill that knowledge

SC CTSI and UCLA CTSI are partnering with LA County Department of Health Services (the country’s second-largest municipal health system) on a novel program to improve healthcare for underserved, high-disparity populations. Our aim is to leverage effective healthcare interventions to improve access, quality of care, and health outcomes for DHS patients. We have established critical infrastructure

Among the Southern California Clinical and Translational Science Institute's most important services to the research community are their support and tools (https://bit.ly/3qmjIb9) designed to help investigators overcome the all-too-familiar hurdle of clinical study recruitment. As a result, few people are more cognizant of the importance of participation in clinical research than the personnel of

Among the Southern California Clinical and Translational Science Institute's most important services to the research community are their support and tools (https://bit.ly/3qmjIb9) designed to help investigators overcome the all-too-familiar hurdle of clinical study recruitment. As a result, few people are more cognizant of the importance of participation in clinical research than the personnel of

The COVID-19 pandemic has caused illness widely throughout the United States, but some communities have been hit disproportionately hard, such as the Latinx community. To help slow the spread of the pandemic in Los Angeles and Southern California, the Southern California Clinical and Translational Science Institute's (SC CTSI) Community Engagement team has created a new workshop series

The University of Rochester's eighth annual America’s Got Regulatory Science Talent student competition, hosted by the University of Rochester Clinical and Translational Science Institute, drew the largest number of competing teams in its history. On March 4, 2021, twelve teams faced off for a chance at first prize: to present their novel regulatory science ideas to a panel of scientists from the

Laura Calvi, M.D., a prominent cancer researcher at the University of Rochester's Wilmot Cancer Institute, recently achieved what a lot of researchers only dream of: Her years of lab research have translated to a clinical trial that has begun to benefit patients. With the help of a UR CTSI Incubator award, Calvi’s discoveries from the lab are starting to have a tangible impact on patients with

How research is conducted is an important topic. Scientists must balance several principles when conducting research with humans. According to the National Institutes of Health, these principles include scientific validity, independent review of the research, and making sure that participants are properly informed before participating. Answers to the scientist's research question should contribute

While the broad architecture and organization of the human brain is universal, researchers supported by the University of Rochester Clinical and Translational Science Institute (UR CTSI) are the first to observe and quantify the differences between how people reimagine common scenarios. These unique neurological signatures could ultimately be used to understand, study, and even improve the

Small molecules are powerful tools for understanding biological systems, and form the foundation for most therapies of human disease. The Boston University Center for Molecular Discovery (BU-CMD) has established an open-access small molecule sharing network that connects chemists who make molecules with biologists who wish to test them in various diseases. This collaborative nexus is designed to